RxDoctor Payments Data

Jonathan Abelson

Colon & Rectal Surgery · New York, NYNPI 1932465077

Payments from drug & device makers

$3,118in general payments, 2019–2025

Across 14 payments — averaging $222.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Intuitive Surgical$725
  • Bolder Surgical, LLC$675
  • Applied Medical Resources Corporation$350
  • THD America, Inc.$179
  • Boston Scientific$132
  • plus $44 from 1 others

What the payments were for

  • Consulting fees$2,03865%
  • Travel & lodging$39913%
  • Food & beverage$61420%
  • Education$672%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic1$1,013
Intuitive Surgical8$725
Bolder Surgical, LLC1$675
Applied Medical Resources Corporation1$350
THD America, Inc.1$179
Boston Scientific1$132
Polarityte, Inc.1$44

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,118 in reported general payments places this provider in the 60th percentile of 177 colon & rectal surgery providers in New York.

See all colon & rectal surgery providers in New York

Medicare billing

Part B allowed, 2024
$115,556
Medicare patients
222
Services billed
535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate14$44
Metronidazole14$19

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →